Effect of inhaler corticosteroid in chronic lung disease

Comparison effect of inhalant corticosteroid after 3 months in patient with COPD with eosinophilia and without it that confer to pulmonology clinic of Zahedan university of medical science in 1397

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181126041758N1

Enrollment

Registered

2019-01-19

Start date

2017-11-22

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention 1: intervention group: Patient with eosinophilia. Intervention 2: Intervention group: Patient without eosinophilia.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: New patient with COPD diagnosis according history and spiromerty data, that was without exacerbation during last 4 week,

Exclusion criteria

Exclusion criteria: Cardiovascular disease Hematologic-oncologic disorder Collagen vascular disease COPD exacerbation during last 4 weeks Use of corticosteroid for ohter cause parasitic infection

Design outcomes

Primary

Measure	Time frame
Change the distance traveled within 6 minutes on a 30-meter interval after 3 months use of inhalation corticosteroids. Timepoint: At first visit and after 3 month. Method of measurement: 6 minute walking test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactOmolbanin Afroushte

Zahedan University of Medical Sciences

O.afroushte@gmail.com+98 54 3332 2436

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026